What is the most common viral pathogen causing bronchopneumonia in a 7‑month‑old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Common Viral Agent in 7-Month-Old with Bronchopneumonia

Respiratory syncytial virus (RSV) is the most common viral pathogen causing bronchopneumonia in a 7-month-old infant.

Age-Specific Viral Etiology

RSV is consistently the most frequently detected viral pathogen in infants under 2 years of age, representing up to 40% of identified pathogens in this age group 1. This makes it the predominant viral cause of lower respiratory tract infections requiring hospitalization in infants 1.

Supporting Evidence from Guidelines

The Pediatric Infectious Diseases Society and Infectious Diseases Society of America guidelines specifically state that:

  • Viral etiologies account for up to 80% of community-acquired pneumonia cases in children younger than 2 years 1
  • RSV is the leading viral pathogen in this age group, while it is rarely identified in older children with pneumonia 1
  • Other viral pathogens detected less frequently include adenoviruses, bocavirus, human metapneumovirus, influenza A and B viruses, parainfluenza viruses, coronaviruses, and rhinovirus 1

Clinical Context

At 7 months of age, this infant falls squarely within the peak age range for RSV infection:

  • 90% of children are infected with RSV in the first 2 years of life, with up to 40% experiencing lower respiratory tract infection during initial infection 2
  • The highest incidence of RSV infection occurs between December and March in North America, though regional variations exist 2

Important Caveats

Co-infections are common in this age group, with 2-33% of hospitalized children with pneumonia simultaneously infected by 2 or more viruses 1. Additionally, viral-bacterial co-infections occur in many cases, making it difficult to determine the significance of any single pathogen 1.

While RSV is the most common viral agent, bacterial pathogens (particularly Streptococcus pneumoniae) must also be considered in the differential diagnosis and treatment approach for bronchopneumonia in this age group 1.

Related Questions

What is the risk of pneumonia associated with placement of a Zephyr endobronchial valve compared with the risk of pneumonia in patients with untreated bronchiectasis?
What is the best antibiotic for an 18‑month‑old child with pneumonia?
In a 68-year-old male who is post‑pneumonia and reports intermittent episodes of sweating and rib pain, with normal vital signs and no other symptoms, what is the appropriate evaluation and management?
In a 70-year-old male discharged from the emergency department after treatment for pneumonia, what is the most appropriate reason for his follow-up visit with his primary care physician: to assess improvement of cough and fever, administer pneumococcal 13-valent vaccine (PCV13), repeat chest X-ray, evaluate for clubbing and barrel chest, or obtain sputum culture?
What aggressive treatment plan can be used for a skilled‑nursing‑facility resident with suspected pneumonia who cannot produce sputum or tolerate nasotracheal suction, without violating standard of care?
What is the recommended methylprednisolone dose, route, and duration for an adult (approximately 70 kg) patient?
Is bilateral hydrosalpinx (fluid‑filled fallopian tubes) a normal finding in early pregnancy?
What is the mortality rate of untreated unstable angina?
What endocrine screening and management should be performed in patients with Marfan syndrome?
What is the recommended discharge medication regimen after a transjugular intrahepatic portosystemic shunt (TIPS) procedure?
What is the optimal detoxification strategy for a patient with ketamine abuse?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.